← Back to Portfolio


VirionHealth is a new biotechnology company developing novel therapeutics for respiratory viral infections, focusing on influenza and respiratory syncytial virus. Founded on the pioneering research of Professors Nigel Dimmock and Andrew Easton at the University of Warwick, the company intends to develop the first broad-spectrum therapy for respiratory viral infections, potentially simplifying and accelerating treatment by removing the need for differential diagnosis.

Location Virtual company, UK
CEO Nicola Thompson
Partner Tim Haines
Website www.virionhealth.com